Study #2022-0494
Targeted Axillary Dissection and Deep Learning Radiomics To Predict Axillary Nodal Burden Pre-Operatively in HR+/Her2-, Node-Positive Breast Cancer Undergoing Upfront Surgery
MD Anderson Study Status
Enrolling
Treatment Agent
Description
TAD and Deep Learning Radiomics to Predict Pre-Operative Axillary Nodal Burden
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Phase II
Physician name:
Puneet Singh
Department:
Breast Surgical Oncology
For general questions about clinical trials:
1-866-403-3911
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.